Teachers Advisors’s Acceleron Pharma XLRN Stock Holding History

Teachers Advisors’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$4.93M	Buy	105,849 +7,496	+8%	+$329K	0.01%	1434
2018 Q4	$4.28M	Buy	98,353 +12,072	+14%	+$603K	0.01%	1403
2018 Q3	$4.94M	Buy	86,281 +3,460	+4%	+$170K	0.01%	1460
2018 Q2	$4.02M	Buy	82,821 +2,450	+3%	+$89.3K	0.01%	1549
2018 Q1	$3.14M	Buy	80,371 +305	+0.4%	+$13K	﹤0.01%	1567
2017 Q4	$3.4M	Buy	80,066 +21,508	+37%	+$807K	﹤0.01%	1544
2017 Q3	$2.19M	Buy	58,558 +642	+1%	+$22.3K	﹤0.01%	1788
2017 Q2	$1.76M	Buy	57,916 +11,836	+26%	+$343K	﹤0.01%	1904
2017 Q1	$1.22M	Buy	46,080 +942	+2%	+$24.8K	﹤0.01%	2075
2016 Q4	$1.15M	Buy	45,138 +1,296	+3%	+$41.1K	﹤0.01%	2102
2016 Q3	$1.59M	Hold	43,842	–	–	﹤0.01%	1814
2016 Q2	$1.49M	Buy	43,842 +5,991	+16%	+$195K	﹤0.01%	1828
2016 Q1	$999K	Buy	37,851 +5,781	+18%	+$168K	﹤0.01%	1962
2015 Q4	$1.56M	Buy	32,070 +606	+2%	+$21.8K	﹤0.01%	1736
2015 Q3	$783K	Sell	31,464 -46,576	-60%	-$1.4M	﹤0.01%	2136
2015 Q2	$2.47M	Buy	78,040 +8,443	+12%	+$272K	﹤0.01%	1552
2015 Q1	$2.65M	Hold	69,597	–	–	0.01%	1472
2014 Q4	$2.71M	Sell	69,597 -100	-0.1%	-$3.48K	0.01%	1435
2014 Q3	$2.11M	Hold	69,697	–	–	﹤0.01%	1562
2014 Q2	$2.37M	Buy	69,697 +11,999	+21%	+$401K	﹤0.01%	1504
2014 Q1	$1.99M	Buy	57,698 +50,438	+695%	+$2.28M	﹤0.01%	1588
2013 Q4	$287K	Buy	+7,260	New	+$175K	﹤0.01%	2690

Other funds holding XLRN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Teachers Advisors's XLRN Position: Q1 2019 in Review

Teachers Advisors increased its Acceleron Pharma (XLRN) stake by 7.6% in Q1 2019, buying an estimated $329K and bringing the position to 105,849 shares worth $4.93M. The position accounts for 0.01% of the portfolio, ranked #1434.

Teachers Advisors first reported a position in XLRN in Q4 2013 and has held it in 22 quarters since. The position peaked at $4.94M in Q3 2018. 171 funds tracked by Wall St. Rank hold XLRN as of Q1 2019.

Teachers Advisors held 105,849 shares of Acceleron Pharma worth $4.93M as of Q1 2019.
Teachers Advisors bought 7,496 Acceleron Pharma shares in Q1 2019, an estimated $329K.
Acceleron Pharma made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1434 holding.
Teachers Advisors first reported a position in Acceleron Pharma in Q4 2013 and has held it in 22 quarters since.
Teachers Advisors's Acceleron Pharma position peaked at $4.94M in Q3 2018.
171 funds tracked by Wall St. Rank held Acceleron Pharma as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.